{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:48:40Z","timestamp":1791348520483,"version":"4.3.1"},"reference-count":28,"publisher":"European Centre for Disease Control and Prevention (ECDC)","issue":"6","license":[{"start":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T00:00:00Z","timestamp":1486598400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,9]]},"abstract":"<jats:p>Using a test-negative design, the Canadian Sentinel Practitioner Surveillance Network (SPSN) assessed interim 2016\/17 influenza vaccine effectiveness (VE) against dominant influenza A(H3N2) viruses considered antigenically matched to the clade 3C.2a vaccine strain. Sequence analysis revealed substantial heterogeneity in emerging 3C.2a1 variants by province and over time. Adjusted VE was 42% (95% confidence interval:\u200918\u201359%) overall, with variation by province. Interim virological and VE findings reported here warrant further investigation to inform potential vaccine reformulation.<\/jats:p>","DOI":"10.2807\/1560-7917.es.2017.22.6.30460","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T11:26:20Z","timestamp":1487244380000},"update-policy":"https:\/\/doi.org\/10.2807\/1560-7917.es.crp2020","source":"Crossref","is-referenced-by-count":60,"title":["Interim estimates of 2016\/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017"],"prefix":"10.2807","volume":"22","author":[{"given":"Danuta M","family":"Skowronski","sequence":"first","affiliation":[{"name":"University of British Columbia, Vancouver, Canada"},{"name":"British Columbia Centre for Disease Control, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharine","family":"Chambers","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Sabaiduc","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Dickinson","sequence":"additional","affiliation":[{"name":"University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Luise","family":"Winter","sequence":"additional","affiliation":[{"name":"Public Health Ontario, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Qu\u00e9bec (University Hospital Centre of Quebec), Qu\u00e9bec, Canada"},{"name":"Laval University, Quebec, Canada"},{"name":"Institut National de Sant\u00e9 Publique du Qu\u00e9bec (National Institute of Health of Quebec), Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Drews","sequence":"additional","affiliation":[{"name":"University of Alberta, Edmonton, Canada"},{"name":"Alberta Provincial Laboratory, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agatha","family":"Jassem","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, Canada"},{"name":"British Columbia Centre for Disease Control, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B","family":"Gubbay","sequence":"additional","affiliation":[{"name":"University of Toronto, Toronto, Canada"},{"name":"Public Health Ontario, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Charest","sequence":"additional","affiliation":[{"name":"Institut National de Sant\u00e9 Publique du Qu\u00e9bec (National Institute of Health of Quebec), Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Balshaw","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, Canada"},{"name":"British Columbia Centre for Disease Control, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bastien","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, Canada"},{"name":"British Columbia Centre for Disease Control, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7995","reference":[{"key":"r1","unstructured":"Public Health Agency of Canada (PHAC). FluWatch report: January 8 to January 14, 2017 (week 2). Ottawa: PHAC; 2017. Available from: http:\/\/www.healthycanadians.gc.ca\/publications\/diseases-conditions-maladies-affections\/fluwatch-2016-2017-02-surveillance-influenza\/index-eng.php?_ga=1.147496691.591173311.1486470400"},{"issue":"4","key":"r2","doi-asserted-by":"crossref","first-page":"21022","DOI":"10.2807\/1560-7917.ES2015.20.4.21022","article-title":"Interim estimates of 2014\/15 vaccine effectiveness against influenza A(H3N2) from Canada\u2019s Sentinel Physician Surveillance Network, January 2015.","volume":"20","author":"Skowronski","year":"2015","journal-title":"Euro Surveill"},{"issue":"1","key":"r3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/cid\/ciw176","article-title":"A perfect storm: Impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014-2015 season.","volume":"63","author":"Skowronski","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"25","key":"r4","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1056\/NEJMoa0903810","article-title":"Emergence of a novel swine-origin influenza A (H1N1) virus in humans.","volume":"360","author":"Dawood","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"r5","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/JCM.02184-10","article-title":"Simultaneous detection of influenza A, influenza B, and respiratory syncytial viruses and subtyping of influenza A H3N2 virus and H1N1 (2009) virus by multiplex real-time PCR.","volume":"49","author":"Chen","year":"2011","journal-title":"J Clin Microbiol"},{"key":"r6","unstructured":"Allplex Respiratory Panel Assay. Seoul: Seegene. Available from: http:\/\/seegene.com\/neo\/en\/products\/respiratory\/allplex_Rp_fp.php"},{"key":"r7","unstructured":"NxTAG Respiratory Pathogen Panel (RUO). Luminex. Available from: https:\/\/www.luminexcorp.com\/clinical\/ruo-products\/nxtag-respiratory-pathogen-panel\/"},{"issue":"21","key":"r8","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1073\/pnas.0903427106","article-title":"Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines.","volume":"106","author":"Ndifon","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6161","key":"r9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1126\/science.1244730","article-title":"Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.","volume":"342","author":"Koel","year":"2013","journal-title":"Science"},{"key":"r10","unstructured":"Public Health Agency of Canada (PHAC). FluWatch report: August 14 to August 27, 2016 (weeks 33-34). Ottawa: PHAC; 2016. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/fluwatch-report-august-14-27-2016-weeks-33-34.html"},{"key":"r11","unstructured":"Public Health Agency of Canada (PHAC). FluWatch report: August 16 to August 29, 2015 (weeks 33 & 34). Ottawa: PHAC; 2015. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/fluwatch-report-august-16-29-2015-weeks-33-34.html"},{"key":"r12","unstructured":"Public Health Agency of Canada (PHAC). FluWatch report: August 11 to August 24, 2013 (weeks 33 & 34). Ottawa: PHAC; 2013. Available from: http:\/\/publications.gc.ca\/collections\/collection_2013\/aspc-phac\/HP58-1-2013-34-eng.pdf"},{"issue":"8","key":"r13","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"r14","unstructured":"European Centre for Disease Prevention and Control (ECDC). Risk assessment of seasonal influenza, EU\/EEA, 2016-2017: Update, 25 January 2017. Stockholm: ECDC; 2017. Available from: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/Risk-assessment-seasonal-influenza-2016-2017-update.pdf"},{"issue":"11","key":"r15","doi-asserted-by":"crossref","first-page":"e80481","DOI":"10.1371\/journal.pone.0080481","article-title":"Estimating influenza deaths in Canada, 1992-2009.","volume":"8","author":"Schanzer","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"r16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States.","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"24","key":"r17","doi-asserted-by":"crossref","first-page":"14001","DOI":"10.1073\/pnas.96.24.14001","article-title":"Variable efficacy of repeated annual influenza vaccination.","volume":"96","author":"Smith","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"r18","unstructured":"World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2016-2017 northern hemisphere influenza season. Geneva: WHO; 2016. Available from: http:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/2016_17_north\/en\/"},{"key":"r19","unstructured":"The Francis Crick Institute. September 2016 interim report. London: The Crick Worldwide Influenza Centre (WIC); 2016. Available from: https:\/\/www.crick.ac.uk\/media\/326439\/september_2016_interim_report.pdf"},{"key":"r20","unstructured":"European Centre for Disease Prevention and Control (ECDC). Influenza virus characterisation, summary Europe, September 2016. Stockholm: ECDC; 2016. Available from: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/influenza-virus-characterisation-september-2016.pdf"},{"issue":"21","key":"r21","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1093\/bioinformatics\/btv381","article-title":"nextflu: real-time tracking of seasonal influenza virus evolution in humans.","volume":"31","author":"Neher","year":"2015","journal-title":"Bioinformatics"},{"issue":"3","key":"r22","doi-asserted-by":"crossref","first-page":"30112","DOI":"10.2807\/1560-7917.ES.2016.21.3.30112","article-title":"Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses.","volume":"21","author":"Skowronski","year":"2016","journal-title":"Euro Surveill"},{"issue":"7","key":"r23","doi-asserted-by":"crossref","first-page":"e41895","DOI":"10.1371\/journal.pone.0041895","article-title":"Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses.","volume":"7","author":"Popova","year":"2012","journal-title":"PLoS One"},{"issue":"18","key":"r24","doi-asserted-by":"crossref","first-page":"9605","DOI":"10.1128\/JVI.78.18.9605-9611.2004","article-title":"Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A\/H3N2 virus hemagglutinin.","volume":"78","author":"Abe","year":"2004","journal-title":"J Virol"},{"issue":"3","key":"r25","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/v6031294","article-title":"Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.","volume":"6","author":"Tate","year":"2014","journal-title":"Viruses"},{"issue":"9","key":"r26","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1021\/acs.jproteome.5b00416","article-title":"Glycosylation analysis of engineered H3N2 influenza A virus hemagglutinins with sequentially added historically relevant glycosylation sites.","volume":"14","author":"An","year":"2015","journal-title":"J Proteome Res"},{"issue":"16","key":"r27","doi-asserted-by":"crossref","first-page":"30202","DOI":"10.2807\/1560-7917.ES.2016.21.16.30202","article-title":"Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review.","volume":"21","author":"Leung","year":"2016","journal-title":"Euro Surveill"},{"issue":"3","key":"r28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/ije\/dym021","article-title":"Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.","volume":"36","author":"Orenstein","year":"2007","journal-title":"Int J Epidemiol"}],"container-title":["Eurosurveillance"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T13:35:00Z","timestamp":1663248900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/1560-7917.ES.2017.22.6.30460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,9]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,2,9]]}},"URL":"https:\/\/doi.org\/10.2807\/1560-7917.es.2017.22.6.30460","relation":{},"ISSN":["1560-7917"],"issn-type":[{"value":"1560-7917","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2,9]]}}}